Researchers at a state-invested infectious disease research institute have found that Covid-19 pills and injections are effective against Omicron’s four subvariants, quarantine authorities said Thursday.At a Central Disease Control Headquarters meeting, Kwon Jun-wook, director of the National Instit
Yuyu Pharmaceutical’s phase 2 clinical trial of YP-P10, a xerophthalmia treatment, is proceeding smoothly in the U.S. by completing its first patient registration, the company said Thursday.The clinical trial, which received approval from the U.S. Food and Drug Administration in April, is to evaluat
Physicians are increasingly emphasizing the importance of managing heart failure (HF), the final complication of cardiovascular disease, and Bayer’s new treatment Verquvo (vericiguat), is drawing attention from the medical community.According to the Korea Heart Failure Fact Sheet released by the Kor
Biopharma experts said that the government should maintain or expand the accelerated review of approval for innovative medicines even after Covid-19 becomes endemic.On Thursday, they gathered at a special forum on the “2022 Cytiva Global Biopharma Resilience Index” at the Westin Chosun Hotel in cent
Matica Biotechnology, CHA Biotech’s U.S. offshoot, said Thursday that it aims to achieve annual sales of 1 trillion won ($762 million) in 2030, emerging as one of the big-five cell and gene therapy CDMOs worldwide."The cell and gene therapy (CGT)’s contract development, and manufacturing organizatio
The share price of Lunit, an artificial intelligence-based medical equipment manufacturer, rose to its upper limit on Thursday, the first day of its initial public offering on the tech-heavy Kosdaq market.Lunit’s share price surged 29.87 percent to close at 40,000 ($30.56) won per share.The surge in
The Korea Advanced Institute of Science and Technology (KAIST) has developed a polychromatic quantum dot array (PQDA), which can detect microRNAs related to various cancers.MicroRNA is a short RNA comprised of 18 to 25 sequence listing, which restricts diverse cell activities such as cell growth and
Myongji Medical Foundation held the inauguration ceremony of its new director, Hong Sung-hwa, at Myongji Hospital in Goyang, Gyeonggi Province, on Wednesday.Attending the ceremony were about 300 dignitaries from various walks of life, including Myongji Hospital Chairman Lee Wang-jun and President Ki
The Ministry of Food and Drug Safety (MFDS) said Wednesday that it has begun the preliminary review of the non-clinical and clinical trials results of Moderna’s Spikevax-2 mRNA Covid-19 vaccine submitted by Moderna Korea.Moderna’s Spikevax-2 is a multi-vaccine containing mRNA that expresses the anti
Ildong Pharmaceutical’s shares plunged to the lower limits on Thursday, as the Japanese regulator delayed giving emergency use approval (EUA) for Xocova, an oral Covid-19 treatment co-developed by Ildong and its Japanese partner, Shionogi Pharmaceutical.As of noon, Ildong’s shares stood at 37,400 wo
Researchers at Gangnam Severance Hospital have established a 3D organoid culturing method that simulates the shape and function of salivary glands for patient-specific salivary gland cancer treatment.Salivary glands aid digestion and vocalization and secrete saliva that maintains the human body's im
Novartis’ Zolgensma (onasemnogene abeparvovec), the world’s most expensive drug yet to treat spinal muscular atrophy (SMA), will become reimbursable in August, the government said.The government set the maximum reimbursement price of the treatment at 2 billion won ($1.52 million), but the out-of-the
The government announced additional steps Wednesday to prepare for Covid-19 resurgence by, for instance, securing 4,000 hospital beds, based on the prediction that the daily infections could soar to 300,000 at its peak.The new measures came in addition to steps announced a week ago, as the resurge p
HLB's targeted anticancer drug, rivoceranib, has proven excellent efficacy, with 85 percent of patients showing cancer disappearance and more than 30 percent reduction in adenocarcinoma treatment for local progressive esophageal squamous cell cancer (ESCC).Following the recent successful clinical re
Korean researchers have developed technology to diagnose infections by Covid-19 variants immediately on the spot.According to the Korea Research Institute of Bioscience and Biotechnology (KRIBB), a research team led by Dr. Kang Tae-joon of the Bio-nanotechnology Research Center has developed a biose
The ongoing strength of the U.S. dollar will likely result in mixed fortunes for Korean biopharmaceutical and biotech companies in the second quarter, according to industry analysts on Wednesday.According to the Korea International Trade Association, the Korean currency ended Wednesday’s trading at
In 2021, Korean biotech firm Bixink Therapeutics introduced Nerlynx Tab. (neratinib), a HER2 inhibiting breast cancer treatment developed by Puma Biotechnology and approved by the FDA in July 2017. The arrival of the drug drew much attention from the medical community.In Korea, Nerlynx obtained appr
Seegene, a company specializing in molecular diagnostics, will launch its “In-Life PCR” test in Vietnam to protect drivers and passengers of Grab, a ride-sharing service, with the local testing company, LabHouse, in August.The In-Life PCR is a global campaign initiated by Seegene to quickly identify
Daewoong Pharmaceutical said it has completed preparations for speeding up its entry into the contract development and manufacturing organization (CDMO) business.The company said Wednesday that it received approval for an advanced regenerative medicine cell processing facility from the Ministry of F
Takeda’s oral drug Exkivity (mobocertinib) won the regulatory nod to treat non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion (Ex20ins) mutation in Korea.The approval will prompt its competition against Janssen’s Rybrevant (amivantamab), an injection th